171 related articles for article (PubMed ID: 37483781)
1. The anti-SARS-CoV-2 effect and mechanism of Chiehyuan herbal oral protection solution.
Wu CY; Yang YH; Lin YS; Shu LH; Cheng YC; Liu HT; Lin YY; Lee IY; Shih WT; Yang PR; Tsai YY; Chang GH; Hsu CM; Yeh RA; Wu YH; Wu YH; Shen RC; Tsai MS
Heliyon; 2023 Jul; 9(7):e17701. PubMed ID: 37483781
[TBL] [Abstract][Full Text] [Related]
2. Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations.
Tsai MS; Shih WT; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
Biomed Pharmacother; 2022 May; 149():112802. PubMed ID: 35279013
[TBL] [Abstract][Full Text] [Related]
3. GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.
Tsai MS; Yang YH; Lin YS; Chang GH; Hsu CM; Yeh RA; Shu LH; Cheng YC; Liu HT; Wu YH; Wu YH; Shen RC; Wu CY
Biomed Pharmacother; 2021 Oct; 142():112011. PubMed ID: 34388530
[TBL] [Abstract][Full Text] [Related]
4. Binding Interactions between Receptor-Binding Domain of Spike Protein and Human Angiotensin Converting Enzyme-2 in Omicron Variant.
Jawad B; Adhikari P; Podgornik R; Ching WY
J Phys Chem Lett; 2022 May; 13(17):3915-3921. PubMed ID: 35481766
[TBL] [Abstract][Full Text] [Related]
5. Binding of human ACE2 and RBD of Omicron enhanced by unique interaction patterns among SARS-CoV-2 variants of concern.
Kim S; Liu Y; Ziarnik M; Seo S; Cao Y; Zhang XF; Im W
J Comput Chem; 2023 Feb; 44(4):594-601. PubMed ID: 36398990
[TBL] [Abstract][Full Text] [Related]
6. Omicron variant (B.1.1.529) of SARS-CoV-2: understanding mutations in the genome, S-glycoprotein, and antibody-binding regions.
Bhattacharya M; Sharma AR; Dhama K; Agoramoorthy G; Chakraborty C
Geroscience; 2022 Apr; 44(2):619-637. PubMed ID: 35258772
[TBL] [Abstract][Full Text] [Related]
7. Mutational Analysis of Circulating Omicron SARS-CoV-2 Lineages in the Al-Baha Region of Saudi Arabia.
Almalki SSR; Izhari MA; Alyahyawi HE; Alatawi SK; Klufah F; Ahmed WAM; Alharbi R
J Multidiscip Healthc; 2023; 16():2117-2136. PubMed ID: 37529147
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 in relation to global vaccination and booster doses: what is the future of vaccination in the battle against COVID-19?
Khalid N; Wheeler AM
Bratisl Lek Listy; 2022; 123(9):631-633. PubMed ID: 36039880
[TBL] [Abstract][Full Text] [Related]
9. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
[TBL] [Abstract][Full Text] [Related]
10. Omicron (B.1.1.529) - A new heavily mutated variant: Mapped location and probable properties of its mutations with an emphasis on S-glycoprotein.
Chakraborty C; Bhattacharya M; Sharma AR; Mallik B
Int J Biol Macromol; 2022 Oct; 219():980-997. PubMed ID: 35952818
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain.
Pitsillou E; Liang JJ; Beh RC; Hung A; Karagiannis TC
Comput Biol Med; 2022 Oct; 149():106035. PubMed ID: 36055162
[TBL] [Abstract][Full Text] [Related]
12. Differential Interactions Between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
bioRxiv; 2021 Jul; ():. PubMed ID: 34341794
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis.
Kong X; Gao P; Jiang Y; Lu L; Zhao M; Liu Y; Deng G; Zhu H; Cao Y; Ma L
Virol J; 2023 Aug; 20(1):192. PubMed ID: 37626353
[TBL] [Abstract][Full Text] [Related]
14. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
[TBL] [Abstract][Full Text] [Related]
15. Omicron: A Heavily Mutated SARS-CoV-2 Variant Exhibits Stronger Binding to ACE2 and Potently Escapes Approved COVID-19 Therapeutic Antibodies.
Shah M; Woo HG
Front Immunol; 2021; 12():830527. PubMed ID: 35140714
[TBL] [Abstract][Full Text] [Related]
16. Molecular insights into the SARS-CoV-2 Omicron variant from Bangladesh suggest diverse and continuous evolution.
Afrin SZ; Sathi FA; Nooruzzaman M; Parvin R
Virology; 2023 Oct; 587():109882. PubMed ID: 37757731
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the unique Q493R mutation increases the affinity of Omicron S1-RBD for ACE2.
Philip AM; Ahmed WS; Biswas KH
Comput Struct Biotechnol J; 2023; 21():1966-1977. PubMed ID: 36936816
[TBL] [Abstract][Full Text] [Related]
18. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge.
Shi J; Zheng J; Zhang X; Tai W; Odle AE; Perlman S; Du L
Transl Res; 2022 Oct; 248():11-21. PubMed ID: 35489692
[TBL] [Abstract][Full Text] [Related]
19. Binding of Human ACE2 and RBD of Omicron Enhanced by Unique Interaction Patterns Among SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Ziarnik M; Cao Y; Zhang XF; Im W
bioRxiv; 2022 Jan; ():. PubMed ID: 35118473
[TBL] [Abstract][Full Text] [Related]
20. Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients.
Pavia G; Quirino A; Marascio N; Veneziano C; Longhini F; Bruni A; Garofalo E; Pantanella M; Manno M; Gigliotti S; Giancotti A; Barreca GS; Branda F; Torti C; Rotundo S; Lionello R; La Gamba V; Berardelli L; Gullì SP; Trecarichi EM; Russo A; Palmieri C; De Marco C; Viglietto G; Casu M; Sanna D; Ciccozzi M; Scarpa F; Matera G
J Med Virol; 2024 Jun; 96(6):e29708. PubMed ID: 38804179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
